Login / Signup

In vivo and in silico evaluations of a synthetic pyrano[3,2-c]quinoline derivative as a potent anti-diabetic agent.

Nafiseh ZareFatemeh BandarianEnsieh Nasli EsfahaniBagher LarijaniMohammad MahdaviMaryam Mohammadi-KhanaposhtaniHossein Najafzadehvarzi
Published in: Journal of diabetes and metabolic disorders (2023)
evaluations are recommended to comprehensively assess its potential as a new drug for the treatment of diabetes.
Keyphrases
  • type diabetes
  • molecular docking
  • cardiovascular disease
  • glycemic control
  • metabolic syndrome
  • anti inflammatory
  • adipose tissue
  • skeletal muscle
  • drug induced
  • water soluble